Journal Article

DKFZ-2024-02756

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

Laurent, P.-A. ; André, F. ; Bobard, A. ; Deandreis, D. ; Demaria, S. ; Depil, S. ; Eichmüller, S.DKFZ* ; Fernandez-Palomo, C. ; Foijer, F. ; Galluzzi, L. ; Galon, J. ; Guckenberger, M. ; Harrington, K. J. ; Herrera, F. G. ; Huber, P.DKFZ* ; Italiano, A. ; Karam, S. D. ; Kroemer, G. ; Lambin, P. ; Leuschner, C. ; Mantovani, A. ; Meylan, E. ; Mondini, M. ; Pittet, M. J. ; Pouget, J.-P. ; Remon, J. ; Sørensen, C. S. ; Sotiriou, C. ; Vanpouille-Box, C. ; Weichselbaum, R. R. ; Welsh, J. W. ; Zitvogel, L. ; Formenti, S. C. ; Deutsch, E.

2025
Taylor & Franics Abingdon

This record in other databases:

Please use a persistent id in citations: doi:10.1080/2162402X.2024.2432726

Abstract: Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring the latest advancements in the fields of tumor immunology and radiotherapy-immunotherapy combinations for the treatment of cancer. Gathering medical oncologists, radiation oncologists, physicians and researchers with esteemed expertise in these fields, the Immunorad Conference bridges the gap between preclinical outcomes and clinical opportunities. Thus, it paves a promising way toward optimizing radiotherapy-immunotherapy combinations and, from a broader perspective, improving therapeutic strategies for patients with cancer. Herein, we report on the topics developed by key-opinion leaders during the 7th Immunorad Conference held in Paris-Les Cordeliers (France) from September 27th to 29th 2023, and set the stage for the 8th edition of Immunorad which will be held at Weill Cornell Medical College (New-York, USA) in October 2024.

Keyword(s): Humans (MeSH) ; Neoplasms: immunology (MeSH) ; Neoplasms: radiotherapy (MeSH) ; Neoplasms: therapy (MeSH) ; Immunotherapy: methods (MeSH) ; Combined Modality Therapy (MeSH) ; Radiotherapy: methods (MeSH) ; Cancer ; FLASH radiotherapy ; T cells ; immune checkpoint ; immunorad ; immunotherapy ; low-dose radiotherapy ; lymph-node sparing ; radiotherapy ; tumor-associated macrophages

---

Contributing Institute(s):

1. GMP-Einheit Zelluläre Therapie (D210)
2. E055 KKE Molekulare Radioonkologie (E055)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2025

---

Database coverage:
; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---